Doenças crônicas não transmissíveis como fatores de risco para o agravo da Covid - 19 no Estado da Paraiba e no Município de Cuité.

Abstract

Chronic non-communicable diseases (NCDs) are a set of conditions with multiple causes that affect thousands of people around the world. In view of the public health crisis that the world is facing due to the COVID-19 pandemic, CNCDs assume a possible relationship with the worsening of people infected with the coronavirus. Thus, the aim of this study was to know and assess the prevalence of CNCDs as a risk factor for the worsening of COVID-19 in the state of Paraíba and in the municipality of Cuité. This study had as methodology, an integrative review through literature searches, available in electronic databases, with the objective of obtaining scientific articles, journals, epidemiological bulletins that addressed the subject. The research was conducted from May to September 2021 through files available in the following electronic databases: Capes Journals, Electronic Libary Online (SciElo), Virtual Health Library (VHL), Science Direct, Pubmed, Medline, Databases data from official websites in Brazil, from 2016 to 2021. In Paraíba, in 2020, the city most affected by COVID-19 was the capital, where male individuals were the most affected by the disease, with 63% . People who were affected by COVID-19 and who had more severe clinical manifestations had the three main CNCDs, such as heart disease (31%), DM (30%) and hypertension (13%). All studies reveal, in fact, the relationship between CNCDs and COVID-19. Thus, it is concluded that the prevalence of CNCD is high in patients affected with COVID-19, not only in the state of Paraíba, but throughout Brazil, and this relationship brings complications of the disease, which may even lead to the individual's death. . In this sense, the Pharmacist is of paramount importance in the management and control of CNCDs, as well as in patient care, promoting health, improving Pharmacotherapy, establishing well-being and preventing diseases, especially in the face of the new coronavirus pandemic, either in person or through technologies that maintain distance, such as Telepharmacy.